Molecular Diagnostics System Extends Reach
Under a nonexclusive agreement, Henry Schein will market Cepheid’s GeneXpert system to its non-acute care laboratory customers in the United States.
Read MorePosted by Elaine Sanchez Wilson | Feb 8, 2016 | Molecular Diagnostics |
Under a nonexclusive agreement, Henry Schein will market Cepheid’s GeneXpert system to its non-acute care laboratory customers in the United States.
Read MorePosted by Elaine Sanchez Wilson | Jan 8, 2016 | Disease States |
The One Health concept gives a name to the reality that the next public health crisis could be caused by an avian influenza that jumps to humans or by drinking water supplies contaminated by run-off from a nearby farm.
Read MorePosted by Steve Halasey | Dec 16, 2015 | Molecular Diagnostics |
Partners launch next-generation sequencing service for epidemiological monitoring of bacterial infections.
Read MorePosted by Steve Halasey | Dec 11, 2015 | Flu & Respiratory Infections, Infectious Diseases, Molecular Diagnostics |
CLIA-waived test promises the accuracy of reference laboratory tests for performance at the point of care.
Read MorePosted by Steve Halasey | Nov 25, 2015 | Research |
With support from the US Centers for Disease Control and Prevention, DC’s public health agencies and healthcare facilities will examine the occurrence of “superbugs” in a first-of-its-kind citywide evaluation.
Read More